Welcome to our dedicated page for Ingevity SEC filings (Ticker: NGVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating the environmental liabilities hidden in Ingevity’s 200-page 10-K or tracking resin cost swings across three segments can feel overwhelming. Ingevity’s specialty chemical operations—Performance Chemicals, Advanced Polymer Technologies, and activated-carbon-driven Performance Materials—create dense disclosures that analysts must sift through line by line.
Our platform turns that burden into clarity. Stock Titan delivers AI-powered summaries for every document, from the Ingevity annual report 10-K simplified to an Ingevity quarterly earnings report 10-Q filing. Need the latest Ingevity 8-K material events explained after a caprolactone plant outage? Want Ingevity Form 4 insider transactions real-time alerts before the market opens? We stream filings directly from EDGAR, tag key metrics such as segment EBITDA or remediation accruals, and answer natural questions like “understanding Ingevity SEC documents with AI.”
Here’s how professionals use the page:
- Monitor Ingevity insider trading Form 4 transactions and gauge executive confidence.
- Compare asphalt-additive margin trends with our Ingevity earnings report filing analysis.
- Review the Ingevity proxy statement executive compensation to align pay with performance.
Every filing—10-K, 10-Q, 8-K, DEF 14A, S-8, and more—is parsed, highlighted, and cross-linked. Whether you’re screening Ingevity executive stock transactions Form 4 or simply want Ingevity SEC filings explained simply, our real-time updates and expert context keep you ahead of the curve.
Ingevity Corp senior vice president of operations Clarence Reid Clontz, Jr. reported his beneficial ownership in the company as of the stated event date. He directly holds 7,029 shares of common stock.
He also holds employee stock options granted under the Ingevity Corporation 2016 Omnibus Incentive Plan. These options cover 217 shares at $53.11 per share that vested in full on February 27, 2020, 496 shares at $74.91 per share that vested in full on February 28, 2021, and 351 shares at $115.22 per share that vested in three equal installments between February 28, 2020 and February 28, 2022.
Ingevity Corporation reported upcoming leadership changes in its finance and operations teams. The company announced that Executive Vice President and Chief Financial Officer Mary Dean Hall will transition out of her CFO role effective May 1, 2026, and then serve in an advisory capacity for one year to support continuity.
Phillip J. Platt, currently Senior Vice President, Finance and Chief Accounting Officer, has been appointed to succeed her as Senior Vice President and Chief Financial Officer and will join the executive leadership team on May 1, 2026. Platt has been with Ingevity since 2015 in multiple senior finance roles, including leading implementation of the global ERP system and overseeing financial reporting, treasury, investor relations, and business transformation.
The company also disclosed that Richard White, Senior Vice President and President, Performance Chemicals, will depart on May 1, 2026 after moving to a special projects role beginning January 1, 2026. A related press release also announced the appointment of Clarence Reid Clontz, Jr. as Senior Vice President, Operations.
Ingevity Corporation reported that it has completed its previously announced portfolio review and is exploring strategic alternatives for its Advanced Polymer Technologies segment and its Performance Chemicals Road Markings business. This means the company is formally assessing options such as potential sales, partnerships, or other structural changes for these operations.
The company also stated that, as part of its efforts to return meaningful capital to stockholders, it has completed over $30 million in stock repurchases during the fourth quarter of 2025. These buybacks reduce the number of shares in the market and represent a direct way of returning cash to shareholders.
Ingevity Corporation is updating how it reports its results to reflect a planned divestiture of major businesses. The company has an Asset Purchase Agreement with Mainstream Pine Products, LLC for the sale of substantially all assets and certain liabilities of its industrial specialties product line (excluding specified products and businesses) and its North Charleston, South Carolina crude tall oil refinery, with closing expected by early 2026.
Ingevity determined that these operations meet the criteria to be classified as held for sale and that the divestiture represents a strategic shift that will have a major effect on its operations and results. As a result, the industrial specialties product line and the refinery are now presented as discontinued operations for all periods shown. Ingevity is furnishing unaudited recast condensed consolidated statements of operations, segment operating results, and certain non-GAAP financial measures for full-year 2024 and 2023 and multiple 2024–2025 quarters, which apply these changes retrospectively and are described as preliminary.
Ingevity Corp (NGVT) insider filing reports no beneficial ownership. A company officer, identified as the Senior Vice President and President of Performance Materials, filed an initial ownership report on Form 3 as of 11/10/2025. The filing states that no securities are beneficially owned by the reporting person at this time. The form is submitted as an individual filing and includes a power of attorney authorizing an attorney-in-fact to sign on the reporting person’s behalf.
Ingevity Corporation (NGVT) reported steady Q3 2025 results. Net sales were $333.1 million versus $333.8 million a year ago, and gross profit rose to $133.9 million from $131.6 million. Income from continuing operations before taxes was $62.2 million (vs. $54.0 million), with net income of $43.5 million. Diluted EPS was $1.18 versus $(2.94), reflecting a large discontinued-operations loss in the prior year. The effective tax rate was 34.4%.
Year‑to‑date, net sales were $912.5 million (vs. $936.8 million) and net loss was $(82.5) million, driven by a non‑cash $183.8 million goodwill impairment in Advanced Polymer Technologies. Operating cash flow improved to $234.1 million (vs. $64.1 million). Total debt including finance leases declined to $1.2639 billion from $1.4052 billion, and interest expense fell to $56.4 million (vs. $69.3 million). Revolver covenants remained comfortable, with net leverage at 2.7x and interest coverage at 5.5x.
The company signed an Asset Purchase Agreement on September 3, 2025 to divest its industrial specialties product line and North Charleston CTO refinery, which are presented as discontinued operations; closing is expected by early 2026. During Q3, NGVT repurchased $25.2 million of stock, or 445,724 shares at a weighted average of $56.09.
Ingevity Corporation furnished preliminary financial results for the three and nine months ended September 30, 2025. The details are provided in a press release attached as Exhibit 99.1, dated November 5, 2025. The information under Item 2.02, including Exhibit 99.1, is being furnished and is not deemed filed under the Securities Exchange Act. Additional materials may be available on Ingevity’s investor relations website.
Victory Capital Management, Inc. filed an amended Schedule 13G (Amendment No. 1) reporting beneficial ownership of 782,930 shares of Ingevity Corp (NGVT) common stock, representing 2.15% of the class as of 09/30/2025. The filer is classified as an investment adviser (IA).
Victory reports 766,969 shares with sole voting power and 782,930 shares with sole dispositive power, with no shared voting or dispositive power. The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control.
Ingevity Corporation appointed Ruth Castillo as Senior Vice President and President, Performance Materials, effective November 10, 2025. She will report directly to the President and Chief Executive Officer.
Castillo brings over 25 years of experience across chemicals, specialty materials and life sciences, most recently serving as Vice President of Global Chemicals at Avantor. Prior roles at Avantor included business transformation, supply chain and engineering, and global product management, following 17 years in leadership positions at Celanese. She holds an MBA from the University of Texas at Dallas and a B.S. in Chemical Engineering from Universidad Iberoamericana. The company disclosed no family relationships, selection arrangements, or related-party transactions.
Ingevity Corp (NGVT) director Luis Fernandez-Moreno reported a sale and adjustments to his holdings tied to restricted stock units. On
The Form 4 was filed as an individual report and bears a signature submitted by an attorney-in-fact on behalf of Mr. Fernandez-Moreno on
FAQ
What is the current stock price of Ingevity (NGVT)?
What is the market cap of Ingevity (NGVT)?
